tiprankstipranks
pc:splic

SpliceBio

Baldiri Reixac 10-12 Parc Cientific de Barcelona Barcelona, Barcelona 08028, ES
https://www.splice.bio/
SpliceBio is a clinical-stage genetic medicines company specializing in Protein Splicing technology to treat diseases caused by mutations in large genes. The company is advancing its lead program, SB-007, for Stargardt disease and is developing a broader pipeline targeting indications in ophthalmology, neurology, and other therapeutic areas.

Leadership & Board

Current Number of Employees56
Current LinkedIn Followers10,316

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$135M
Total Amount Raised$135M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$135M
Latest Funding Amount$135M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

SpliceBio had 56 employees as of March 23, 2026. The number of employees increased by 0 (0.00%) week-over-week.
56Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

SpliceBio had 10,316 followers as of March 23, 2026. The number of followers increased by 40 (0.39%) week-over-week.
10,316Latest Followers Count
40(0.39%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jun 11, 2025
Series B
$135.00M

Investors

Related News and Analysis